Business Impact of COVID-19
First written in FY2021. 4 of 10 entries say "Restated". Latest entry: FY2025.
3 other companies' latest entry also says "Dropped".
- FY2025DroppedAnnual reportCOVID-19 is no longer described as a standalone risk. The spread of infectious diseases is described more generally under risk items such as natural disasters.
- FY2023RestatedAnnual report
「As no significant impact from COVID-19 was observed during the current consolidated fiscal year, the company has made judgments regarding impairment of fixed assets and the recoverability of deferred tax assets, among other matters, on the assumption that COVID-19 will have no significant impact from the following consolidated fiscal year onward.」
While continuing to assume that no significant impact was observed during the current period, the company also continues to describe the uncertainty of this assumption and the potential impact if the pandemic is prolonged. - FY2023-Q3RestatedAnnual report
「As no significant impact from COVID-19 was observed during the current consolidated accounting period, the company assumed that COVID-19 would have no significant impact from the following consolidated accounting period onward,」
While continuing to assume that no significant impact from the pandemic was observed during the current quarter, the company also describes the uncertainty of this assumption and the potential impact if the pandemic is prolonged. - FY2023-Q2RestatedAnnual report
「As no significant impact from COVID-19 was observed during the current consolidated accounting period, the company assumed that COVID-19 would have no significant impact from the following consolidated accounting period onward,」
The company continues to assume that no significant impact from the pandemic was observed during the current quarter. However, it also continues to describe the uncertainty of this assumption and the potential impact on results if the pandemic is prolonged. - FY2023-Q1RestatedAnnual report
「As no significant impact from COVID-19 was observed during the current consolidated accounting period, the company assumed that COVID-19 would have no significant impact from the following consolidated accounting period onward,」
The company continues to assume that no significant impact from the pandemic was observed during the current quarter. It also continues to describe the uncertainty of this assumption and the potential impact if the pandemic is prolonged. - FY2022MitigatedAnnual report
「As no significant impact from COVID-19 was observed during the current consolidated fiscal year, the company assumed that COVID-19 would have no significant impact from the following consolidated fiscal year onward,」
The company stated that no significant impact from the pandemic was observed during the current consolidated fiscal year. However, it continues to describe the high uncertainty of this assumption and the potential impact if the pandemic is prolonged. - FY2022-Q3WorsenedAnnual report
「In late November, the emergence of the Omicron variant of the novel coronavirus once again raised concerns over the spread of infection, and the uneven situation has continued as efforts are made to balance preventing the spread of the disease with economic activity.」
Following the Delta variant, the emergence of the Omicron variant has raised concerns over a renewed spread of infection, and uncertainty regarding the normalization of economic activity has continued and increased. - FY2022-Q2WorsenedAnnual report
「New challenges have emerged, including the appearance of the Delta variant and the spread of infections among younger people, and the path toward economic normalization has been uneven.」
Although vaccination has driven moves toward normalization, new challenges have emerged, including the appearance of the Delta variant and the spread of infections among younger people, increasing uncertainty over pandemic risks. - FY2022-Q1MitigatedAnnual report
「Although vaccination, regarded as the key to combating COVID-19, has progressed at different rates across countries and is beginning to produce results toward the normalization of socioeconomic activity, the situation has not yet fully escaped uncertainty, but the prolonged lack of visibility is beginning to show some light.」
Uncertainty has eased as vaccination has progressed and economic activity has normalized, and demand for and sales of products have recovered. The company continues to describe the potential impact of a prolonged pandemic. - FY2021First statedAnnual report
「Compared with the previous consolidated fiscal year, our group’s sales volume decreased 16.1% in the first half, increased 7.3% in the second half and decreased 5.2% for the full year.」
Sales volume declined in the first half because of lockdowns and restrictions on sales activities, while demand recovered in the second half. The company describes infection-control measures for potential future outbreaks, including mask-wearing, temperature checks, restrictions on business travel, web conferences and social distancing.